Dues payments are a critical revenue stream for ACCP that allow the society to continue providing essential programing. We are grateful for our colleagues who paid their dues in Q4 before the December 31 st deadline. Your dues payments helps ACCP provide you with tools to enhance your professional growth through CME and CPE accredited educational events, expand your professional network by participating in committees, submitting educational Proposals, attending virtual webinars and the in-person Annual Meeting, plus you can take advantage of everything the ACCP365 Mobile App offers! The January 31st grace period deadline for renewing your ACCP membership is fast approaching. If you have not paid your 2023 ACCP membership dues we encourage you to do so today to support ACCP and avoid a lapse in your membership and losing access to your Member Benefits.
|
|
ACCP Position Papers & Practice Statement |
|
ACCP’s Public Policy Initiative ensures that its views are presented to the public and governmental leaders through manuscripts published to confirm the importance of clinical pharmacology and encourage the optimal use of therapeutics to improve healthcare for all. |
|
Kenneth T. Moore MA, MS, FAHA, Sudhakar M. Pai PhD, FCP, Mark Rogge PhD, FCP, ACCP Public Policy Committee
Pages: 1468-1471 | First Published: 22 August 2022
Kenneth T. Moore MA, MS, FAHA, Oliver Grundmann PhD, MS, MEd, Otito Iwuchukwu PharmD, PhD, MA, FCP, Natella Rakhmanina MD, PhD, FAAP, FCP, AAHIVS, ACCP Public Policy Committee
Pages: 1475-1479 | First Published: 08 September 2022
Kenneth T. Moore MA, MS, FAHA, Michael J. Fossler PharmD, PhD, FCP Jr, Islam Younis PhD, MSc, ACCP Public Policy Committee
Pages: 1465-1467 | First Published: 29 August 2022
Bruce I. Gaynes OD, PharmD, ACCP Public Policy Committee
Pages: 1472-1474 | First Published: 03 September 2022
|
|
2023 ACCP Leadership Development Program |
|
The ACCP Leadership Development Program is a six-month program that provides a structured experience for individual professional growth in the global clinical pharmacology community as well as a pipeline of potential future ACCP Leaders. Best of luck to the 2023 Leadership Development Program participants Sumit Basu, PhD; Simon Berger, MS; Otito Iwuchukwu, RPh, PhD; Yi Ting (Kayla) Lien, PhD and Daisy Zhu, PharmD, PhD! We look forward to your continued support of ACCP and the clinical pharmacology community.
|
|
The Journal of Clinical Pharmacology
Rare Diseases Supplement
|
|
The publication of The Journal of Clinical Pharmacology: Rare Diseases Supplement, Volume 62, Issue S2, was made in December 2022.
Guest Editors: Drs. Mariam A. Ahmed & Indranil Bhattacharya
Many rare diseases exist and until recently, the pharmacologic management of most of them was limited. We are in a new era and many groups are developing drugs to treat a variety of rare diseases. The Rare Diseases Supplement released in December 2022 reviews some general and specific approaches to developing drugs to treat rare diseases. This is an essential read for those involved with drug development in rare diseases as well as for general clinical pharmacologists interested in learning and possibly applying this information to their work.
|
|
ACCP Board of Regents Call for Nominations |
|
Thank you to all who submitted nominations during ACCP's Call for Nominations for the Board of Regents. The Nominating Committee will be evaluating all of the nominees and the slate of candidates will be presented for an election in June 2023. |
|
ACCP Journal Articles to Note |
|
The following Editor's Choice articles are excellent examples of the impact of clinical pharmacology on patient care.
October 2022 - Editor's Choice Article
Sirima Sitaruno PharmD, Wichai Santimaleeworagun PhD, Sutthiporn Pattharachayakul PharmD, Kenneth C. DeBacker BS, Veerapong Vattanavanit MD, Wanrada Binyala PharmD, Manjunath P. Pai PharmD, FCP
Pages: 1215-1226 | First Published: 11 May 2022
November 2022 - Editor's Choice Article
Pradipta Paul, Emmad Janjua, Mai AlSubaie, Vinutha Ramadorai, Beshr Mushannen, Ahamed Lazim Vattoth, Wafa Khan, Khalifa Bshesh, Areej Nauman, Ibrahim Mohammed MD, Imane Bouhali, Mohammed Khalid, Dalia Zakaria PhD
Pages: 1335-1349 | First Published: 06 July 2022
December 2022 - Editor's Choice Article
Borje Darpo MD, PhD, Marie Borin PhD, Georg Ferber PhD, Gerald R. Galluppi PhD, Seth C. Hopkins PhD, Ishani Landry PhD, Arthur Lo PhD, Bhaskar Rege PhD, Larisa Reyderman PhD, Lei Sun PhD, Takao Watanabe PhD, Hongqi Xue PhD, Sally Yasuda PhD
Pages: 1480-1500 | First Published: 05 June 2022
|
|
FEBRURARY
02/16/2023 | 2:00 - 3:00 PM ET
ACCP Virtual Journal Club - CPDD Edition
|
|
ACCP is a Member-focused/Member-driven clinical pharmacology society with
|
|
|
|
|
|
|
